{"data":[{"accessionNo":"0001172661-26-003421","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"CELLECTAR BIOSCIENCES, INC.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BAM GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":798382,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001172661-26-003421","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"CELLECTAR BIOSCIENCES, INC.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BALYASNY ASSET MANAGEMENT L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":798382,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001172661-26-003421","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"CELLECTAR BIOSCIENCES, INC.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Balyasny Asset Management Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":798382,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001172661-26-003421","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"CELLECTAR BIOSCIENCES, INC.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Dames GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":798382,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001172661-26-003421","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"CELLECTAR BIOSCIENCES, INC.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Dmitry Balyasny","reportingCik":null,"personType":"HC,IN","sharesOwned":798382,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001104659-26-096766","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences Inc","ticker":"CLRB","cusip":"15117F880","securityClass":"Class A Common Stock","eventDate":"2026-06-30","reportingPerson":"Devesh Gandhi","reportingCik":null,"personType":"IN","sharesOwned":851285,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001104659-26-096766","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences Inc","ticker":"CLRB","cusip":"15117F880","securityClass":"Class A Common Stock","eventDate":"2026-06-30","reportingPerson":"SilverArc Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":851285,"percentOfClass":9.99,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001104659-26-096752","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common stock, par value $0.00001","eventDate":"2026-06-30","reportingPerson":"StemPoint Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":845740,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001104659-26-096752","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common stock, par value $0.00001","eventDate":"2026-06-30","reportingPerson":"StemPoint Capital Management GP LLC","reportingCik":null,"personType":"OO","sharesOwned":845740,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001104659-26-096752","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common stock, par value $0.00001","eventDate":"2026-06-30","reportingPerson":"Michelle Ross","reportingCik":null,"personType":"HC,IN","sharesOwned":845740,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001727492-26-000017","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"JOHNSON DAVID EDWARD","reportingCik":null,"personType":"HC,IN","sharesOwned":469998,"percentOfClass":5.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001727492-26-000017","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"Caligan Partners LP","reportingCik":null,"personType":"IA,PN","sharesOwned":469998,"percentOfClass":5.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001420506-26-001621","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Shares","eventDate":"2026-06-30","reportingPerson":"Bleichroeder LP","reportingCik":null,"personType":"IA","sharesOwned":808300,"percentOfClass":9.99,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001420506-26-001621","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Shares","eventDate":"2026-06-30","reportingPerson":"Bleichroeder Holdings LLC","reportingCik":null,"personType":"HC","sharesOwned":808300,"percentOfClass":9.99,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001420506-26-001621","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Shares","eventDate":"2026-06-30","reportingPerson":"Andrew Gundlach","reportingCik":null,"personType":"HC","sharesOwned":808300,"percentOfClass":9.99,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0000919574-26-004748","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"Ryan M. Lane","reportingCik":null,"personType":"HC,IN","sharesOwned":864090,"percentOfClass":9.99,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0000919574-26-004748","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"Empery Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":864090,"percentOfClass":9.99,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001274173-26-000157","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"CELLECTAR BIOSCIENCES, INC.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Stock","eventDate":"2026-05-29","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":798382,"percentOfClass":9.99,"filedAt":"2026-06-05","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0000935836-26-000240","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Stock","eventDate":"2026-05-04","reportingPerson":"Jon M. Plexico","reportingCik":null,"personType":"HC,IN","sharesOwned":863277,"percentOfClass":9.9,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0000935836-26-000240","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Stock","eventDate":"2026-05-04","reportingPerson":"Stonepine GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":863277,"percentOfClass":9.9,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0000935836-26-000240","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Stock","eventDate":"2026-05-04","reportingPerson":"Stonepine Capital, L.P.","reportingCik":null,"personType":"PN","sharesOwned":863277,"percentOfClass":9.9,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0000935836-26-000240","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":"15117F880","securityClass":"Common Stock","eventDate":"2026-05-04","reportingPerson":"Stonepine Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":863277,"percentOfClass":9.9,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001420506-26-000425","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":null,"securityClass":"Common Shares","eventDate":"2025-12-31","reportingPerson":"Bleichroeder LP","reportingCik":null,"personType":"IA","sharesOwned":200000,"percentOfClass":4.61,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001420506-26-000425","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":null,"securityClass":"Common Shares","eventDate":"2025-12-31","reportingPerson":"Bleichroeder Holdings LLC","reportingCik":null,"personType":"HC","sharesOwned":200000,"percentOfClass":4.61,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001420506-26-000425","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":null,"securityClass":"Common Shares","eventDate":"2025-12-31","reportingPerson":"Andrew Gundlach","reportingCik":null,"personType":"IN","sharesOwned":200000,"percentOfClass":4.61,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001622627-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":null,"securityClass":"Common Shares","eventDate":"2025-12-31","reportingPerson":"Rosalind Advisors, Inc.","reportingCik":null,"personType":null,"sharesOwned":247715,"percentOfClass":5.5,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001622627-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":null,"securityClass":"Common Shares","eventDate":"2025-12-31","reportingPerson":"SALAMON STEVEN A J","reportingCik":null,"personType":"IN","sharesOwned":247715,"percentOfClass":5.5,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001622627-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":null,"securityClass":"Common Shares","eventDate":"2025-12-31","reportingPerson":"Aharon Gil","reportingCik":null,"personType":"IN","sharesOwned":247715,"percentOfClass":5.5,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001622627-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":null,"securityClass":"Common Shares","eventDate":"2025-12-31","reportingPerson":"Rosalind Master Fund L.P.","reportingCik":null,"personType":"PN","sharesOwned":185036,"percentOfClass":4.1,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001622627-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":9,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":null,"securityClass":"Common Shares","eventDate":"2025-12-31","reportingPerson":"Rosalind Opportunities Fund I L.P.","reportingCik":null,"personType":"PN","sharesOwned":62678,"percentOfClass":1.4,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001753926-26-000263","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"Hexstone Capital LLC","reportingCik":null,"personType":"OO","sharesOwned":216130,"percentOfClass":4.9,"filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001753926-26-000263","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"Brendan O'Neil","reportingCik":null,"personType":"IN","sharesOwned":216130,"percentOfClass":4.9,"filedAt":"2026-02-04","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001420506-25-003303","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":null,"securityClass":"Common Shares","eventDate":"2025-09-30","reportingPerson":"Bleichroeder LP","reportingCik":null,"personType":"IA","sharesOwned":200000,"percentOfClass":6.08,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001420506-25-003303","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":null,"securityClass":"Common Shares","eventDate":"2025-09-30","reportingPerson":"Bleichroeder Holdings LLC","reportingCik":null,"personType":"HC","sharesOwned":200000,"percentOfClass":6.08,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"},{"accessionNo":"0001420506-25-003303","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001279704","issuerName":"Cellectar Biosciences, Inc.","ticker":"CLRB","cusip":null,"securityClass":"Common Shares","eventDate":"2025-09-30","reportingPerson":"Andrew Gundlach","reportingCik":null,"personType":"IN","sharesOwned":200000,"percentOfClass":6.08,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/clrb"}],"updatedAt":"2026-11-05T16:34:10.069Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/clrb","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}